These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 27756881)

  • 1. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
    Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.
    Hsu HC; Liu LC; Wang HY; Hung CM; Lin YC; Ho CT; Way TD
    PLoS One; 2017; 12(1):e0164661. PubMed ID: 28060811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic "nano-spears" for CAFs-targeting: splintered three "shields" with enhanced cisplatin anti-TNBC efficiency.
    Wu Y; Chen R; Ni S; Hu K
    J Control Release; 2024 Jun; 370():556-569. PubMed ID: 38697316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling.
    Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
    Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhein potentiates doxorubicin in treating triple negative breast cancer by inhibiting cancer-associated fibroblasts.
    Xu S; Zheng S; Ma N; Zhang H; Shi J; Huang J; Luo N; Wang M; Xiong Y
    Biochem Pharmacol; 2024 May; 223():116139. PubMed ID: 38499109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts.
    Mediavilla-Varela M; Boateng K; Noyes D; Antonia SJ
    BMC Cancer; 2016 Mar; 16():176. PubMed ID: 26935219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
    Zhang B; Liu Y; Yu J; Lin X
    Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
    Sameni M; Tovar EA; Essenburg CJ; Chalasani A; Linklater ES; Borgman A; Cherba DM; Anbalagan A; Winn ME; Graveel CR; Sloane BF
    Clin Cancer Res; 2016 Feb; 22(4):923-34. PubMed ID: 26432786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Kim JY; Lee N; Kim YJ; Cho Y; An H; Oh E; Cho TM; Sung D; Seo JH
    Cancer Lett; 2017 Feb; 386():151-160. PubMed ID: 27894956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
    Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
    Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
    Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment.
    Liu FL; Mo EP; Yang L; Du J; Wang HS; Zhang H; Kurihara H; Xu J; Cai SH
    Oncotarget; 2016 Jan; 7(4):4122-41. PubMed ID: 26716641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
    Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
    Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
    J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
    Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
    Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer.
    Zhou P; Du X; Jia W; Feng K; Zhang Y
    Signal Transduct Target Ther; 2024 Jun; 9(1):151. PubMed ID: 38910148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
    Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D
    Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.